Equillium Inc at LD Micro Invitational Conference Transcript
Okay, settling in for our next presentation. From Equillium, I'd like to introduce to you Mr. Jason Keyes.
Thank you and welcome, everybody. My name is Jason Keyes; I'm the Chief Financial Officer of Equillium. Appreciate everyone's interest in Equillium. And look forward to introducing the company to you, and letting you know why we're excited about the business.
Before I begin the presentation, just to remind everyone, I will be making forward-looking statements. Actual results may differ due to risks, uncertainties inherent in our business. I would encourage you to take a look at our risk factors that are in our most recently filed 10-Q, which is available on our website under the Investors section.
So Equillium is a clinical-stage biotech company that are leaders in immunobiology. Our mission, since the company was founded in 2017, is to really innovate and develop high-impact, highly novel therapeutics to address autoimmune and inflammatory disorders.
We have a pipeline that's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
